Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Jess E. Maxwell Image

      Jess E. Maxwell, M.D., M.B.A.

      Department of Surgical Oncology, Division of Surgery

      About Dr. Jess E. Maxwell

      I am an assistant professor in the Pancreas Surgery Service in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center. My clinical and research interests focus on patients with gastrointestinal neuroendocrine tumors and pancreatic cancer.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2011University of Iowa Tippie School of Management, Iowa City, Iowa, US, Master of Business Administration, MBA
      2011University of Iowa Carver College of Medicine, Iowa City, Iowa, US, Doctor of Medicine, MD
      2004University of Wisconsin, Madison, Wisconsin, US, Bachelor of Science, BS

      Postgraduate Training

      2025-2025Surgeons as Educators, General Surgery Education, American College of Surgeons, Division of Education, Atlanta, GA
      2022-2022Certification, HPB Advanced Tumor Ablation, Americas Hepato-Pancreato-Biliary Association, New York City, New York
      2022-2022Certification, HPB Ultrasound and Advanced Imaging Technology, Americas Hepato-Pancreato-Biliary Association, New York City, New York
      2020-2020Intensive Seminar, Value-Based Health Care Delivery, Harvard Business School, Boston, Massachusetts
      2018-2020Clinical Fellowship, Complex General Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
      2017-2018Administrative Chief Resident, General Surgery, University of Iowa Carver College of Medicine, Iowa City, IA
      2013-2015Research Fellowship, NIH Research Fellowship (T32), University of Iowa Carver College of Medicine, Iowa City, Iowa
      2012-2018Clinical Residency, General Surgery, University of Iowa Carver College of Medicine, Iowa City, Iowa
      2011-2012Clinical Internship, General Surgery, University of Iowa Carver College of Medicine, Iowa City, Iowa

      Licenses & Certifications

      2022Fellow of the American College of Surgeons (FACS)
      2022American Board of Surgery - Complex General Surgical Oncology
      2019American Board of Surgery - General Surgery
      2018Texas Medical Board

      Experience & Service

      Administrative Appointments/Responsibilities

      Program Director, International Surgical Oncology Fellowship, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present

      Associate Program Director, Complex General Surgical Oncology Fellowship, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2024 - Present

      Director, Quality Improvement and Value-Based Care, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2021 - Present

      Associate Program Director, HPB Surgery Fellowship, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

      Editorial Activities

      Associate Editor, Neuroendocrine Tumor Section, Journal of Surgical Oncology, 2025 - Present

      Member of Editorial Board, Neuroendocrine Tumor Section, Surgical Oncology Insight, 2023 - Present

      Honors & Awards

      2026Travel Award for Research, Society for Surgery of the Alimentary Tract
      2025The John M. Skibber Endowment for Patient Safety in Surgery, The University of Texas MD Anderson Cancer Center
      2025Rising Star Award, North American Neuroendocrine Tumor Society
      2025Inaugural SSAT & TSSG Travel Exchange, Society for Surgery of the Alimentary Tract and the Taiwan Surgical Society of Gastroenterology
      2024MDA Awesome Job Award, The University of Texas MD Anderson Cancer Center
      2024Travel Award for Research, North American Neuroendocrine Tumor Society
      2023Top 10% Provider Team, Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey
      2023MDA Awesome Job Award, The University of Texas MD Anderson Cancer Center
      2022Reviewer of the Month, Journal of Gastrointestinal Oncology
      2022Top 1% Provider Team, Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey
      2021MDA Awesome Job Award, The University of Texas MD Anderson Cancer Center
      2019Travel Award for Research, North American Neuroendocrine Tumor Society
      2019MDA Awesome Job Award, The University of Texas MD Anderson Cancer Center
      2015Travel Award for Research, North American Neuroendocrine Tumor Society
      2015Travel Award for Research, North American Neuroendocrine Tumor Society
      2014Best Basic Science Presentation, American Academy of Endocrine Surgeons
      2014Travel Award for Research, North American Neuroendocrine Tumor Society
      2012Superb Intern, University of Iowa Hospital and Clinics, Department of Family Medicine
      2011Department of Surgery Medical Student of the Year, University of Iowa Carver College of Medicine
      2010MBAA Service Distinction Award, Tippie School of Management
      2010Leadership Award, University of Iowa Carver College of Medicine

      Professional Memberships

      American Society of Clinical Oncology

      2021 - Present

      Americas Hepato-Pancreato-Biliary Association

      2021 - Present

      International Hepato-Pancreato-Biliary Association

      2021 - Present

      Breakthrough Cancer, Pancreas Cancer Team

      2021 - Present

      Texas Medical Association

      2021 - Present

      Society for Surgery of the Alimentary Tract

      2020 - Present

      Pancreas Club

      2020 - Present

      Society of Surgical Oncology

      2020 - Present

      Alliance for Clinical Trials in Oncology

      2020 - Present

      North American Neuroendocrine Tumor Society

      2014 - Present

      American College of Surgeons

      2011 - Present

      Beta Gamma Sigma, Business Honor Society

      2010 - Present

      Selected Presentations & Talks

      National Presentations

      1. 2025. Neuroendocrine Tumor Liver Metastases: Expanding Debulking with Combination Therapy. Invited. NANETS Multidisciplinary Medical Symposium. Austin, Texas, US.
      2. 2025. Neoadjuvant PRRT for Neuroendocrine Tumors. Invited. NANETS Regional Educational Conference. Santa Monica, California, US.
      3. 2025. Role of Perioperative Therapy for Pancreas Neuroendocrine Tumors. Invited. AHPBA Annual Meeting. Miami, FL, US.
      4. 2023. Surgical Management of Metastatic Pancreatic Neuroendocrine Tumors. Invited. Clinical Congress. Boston, MA, US.
      5. 2023. Neuroendocrine Liver Metastases: Surgical Resection vs. Liver-Directed Therapies. Invited. Neuroendocrine Special Session, Digestive Disease Week. San Deigo, CA, US.
      6. 2023. Surgery for Neuroendocrine Liver Metastases: What are the Boundaries?. Invited. Neuroendocrine Symposium, AHPBA Annual Meeting. Miami, FL, US.
      7. 2023. Gastrointestinal Neuroendocrine Tumors: A Surgeon's Perspective. Invited. NET Hands-on Course. Virtual, US.
      8. 2022. Surgical Management of Pancreatic Neuroendocrine Tumors. Invited. Atlanta Pancreas Conference. Atlanta, GA, US.
      9. 2022. Gastro-intestinal Neuroendocrine Hepatic Metastases: A Surgeon's Perspective. Invited. NET Hands-on Course. Virtual, US.
      10. 2022. Surgical Management of Gastrointestinal Neuroendocrine Tumors. Invited. Society of Abdominal Radiology Annual Meeting. Scottsdale, AZ, US.
      11. 2022. Gastro-intestinal Neuroendocrine Hepatic Metastases: A Surgeon's Perspective. Invited. NET Hands-on Course. Virtual, US.
      12. 2021. Surgical Management of Gastrointestinal Neuroendocrine Tumors. Invited. AHPBA Allied Health Professionals Symposium. Virtual, US.
      13. 2021. Controversies in the Management of Pancreatic, Liver, and Jejunoileal Neuroendocrine Tumors. Invited. Southern Society of Clinical Surgeons Annual Meeting. Virtual, US.

      International Presentations

      1. 2026. Gastrointestinal Neuroendocrine Tumors: A Surgeon's Perspective. Invited. Society of Abdominal Radiology Annual Meeting. San Juan, PR.
      2. 2026. Surgical Management of Neuroendocrine Tumor Liver Metastases. Invited. Department of General Surgery. Taipei, TW.
      3. 2025. Surgical Management of Pancreatic Neuroendocrine Tumors. Invited. Taiwan Surgical Society of Gastroenterology. Taipei, TW.
      4. 2025. Trends in GI Surgical Training Pathways: USA. Invited. Taiwan Surgical Society of Gastroenterology. Taipei, TW.
      5. 2025. Neoadjuvant Strategies for Neuroendocrine Tumors. Visiting. Grand Rounds, Professor Tien-Yu Lin Memorial Lecture. Taipei, TW.
      6. 2023. Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors. Poster. NANETS Multidisciplinary Medical Symposium. Montreal, Quebec, US.
      7. 2023. Resection of the Primary Tumor in Metastatic Gastroenteropancreatic NETs. Invited. NANETS Multidisciplinary Medical Symposium. Montreal, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2025 - 2028
      Title:Innovative in vitro and in vivo Patient-derived Cancer Models to Advance Precision Medicine in G1/G2 Gastroenteropancreatic Neuroendocrine Tumors
      Funding Source:CPRIT
      Role:Co-I
      ID:RP250247

      Selected Publications

      Peer-Reviewed Articles

      1. Guo J, Lewis KA, Prakash L, Bhosale P, Morani A, Katz MHG, Tzeng CD, Ikoma N, Snyder R, Kim MP, Chandrasekharan C, Dasari A, Yao JC, Lee JE, Maxwell JE*, Halperin DM*. Primary Tumor Size and Tumor-Vessel Interface Following Capecitabine and Temozolomide for Pancreatic Neuroendocrine Tumors. Curr Oncol 33(2):111, 2026. e-Pub 2026. PMID: 41744875.
      2. Ayabe RI, Seo YD, Melendez B, Fields BC, Diggs LP, Lazcano R, Singh BB, Wani K, Ingram D, Johnson S, Chelvanambi M, Hudgens C, Hernandez SD, Ajami NJ, Wargo JA, Lazar AJ, Knafl M, Woodman S, Halperin DM, Estrella JS, Maxwell JE. Cancer Testis Antigen Expression Correlates With Immune Activation and Survival in Small Bowel Neuroendocrine Tumors. JCO Precis Oncol 9:e2500107, 2025. e-Pub 2025. PMID: 40638874.
      3. Azimuddin A, Tzeng CD, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Newhook TE, Kim MP, Ikoma N, Snyder RA, Lee JE, Perrier ND, Katz MH, Maxwell JE. Postoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical Pathways. J Am Coll Surg 238(4):451-459, 2024. e-Pub 2024. PMID: 38180055.
      4. Boyev A, Prakash LR, Chiang YJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Tzeng CD, Katz MHG, Maxwell JE. Elevated CA 19-9 is Associated with Worse Survival in Patients with Resected Ampullary Adenocarcinoma. Surg Oncol 51:101994, 2023. e-Pub 2023. PMID: 37742542.
      5. Boyev A, Prakash LR, Chiang YJ, Childers CP, Jain AJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Katz MHG, Tzeng CD, Maxwell JE. Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy. J Gastrointest Surg 27(10):2135-2144, 2023. e-Pub 2023. PMID: 37468733.
      6. Concors SJ, Maxwell JE. Neuroendocrine Hepatic Metastatic Disease: the Surgeon's Perspective. Abdom Radiol (NY) 47(12):4073-4080, 2022. e-Pub 2022. PMID: 35476146.

      Review Articles

      1. Maxwell JE, Naraev B, Halperin DM, Choti MA, Halfdanarson TR. Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis. Ann Surg Oncol 29(5):3072-3084, 2022. e-Pub 2022. PMID: 35165817.
      2. Maxwell JE, Katz MHG. Radiotherapy for Resectable and Borderline Resectable Pancreas Cancer: When and Why?. J Gastrointest Surg 25(3):843-848, 2021. e-Pub 2021. PMID: 33205307.

      Professional Educational Materials

      1. Maxwell JE. "Pancreas Surgery", 2022.
      2. Maxwell JE. "HPB Fellowship." GME-compliant handbook for Fellowship Council-accredited HPB fellowship. The University of Texas MD Anderson Cancer Center. 2024.

      Other Articles

      1. Maxwell JE, Ayabe RI, Seo YD, Melendez B, Segura RL, Fields BC, Wani KM, Johnson S, Witt R, Chelvanambi M, Hudgens C, Hernandez SD, Ajami NJ, Wargo JA, Lazar AJ, Halperin DM, Estrella J, Maxwell JE Cancer Testis Antigen Expression Correlates with Type-I Interferon Signaling and Improved Prognosis in Small Bowel Neuroendocrine Tumors. American Society of Clinical Oncology. Poster Presentation, ASCO Gastrointestinal Cancers Symposium,.
      2. Newton, AD, Newhook, TE, Bruno, ML, Prakash, L, Arango, NP, Dewhurst, WL, Arvide, EM, Ikoma, N, Maxwell, JE, Kim, MP, Lee, JE, Katz, MHG, Tzeng, CD Iterative Changes in Risk-stratified Pancreatectomy Clinical Pathways and Factors Associated with Accelerated Discharge after Pancreaticoduodenectomy. Society for Surgery of the Alimentary Tract. Poster presentation, Digestive Disease Week,.
      3. Guo J, Maxwell JE, Prakash L, Bhosale P, Morani A, Katz MHG, Tzeng CD, Ikoma N, Kim MP, Dasari A, Yao JC, Lee JE, Halperin DM Impact of Capecitabine and Temozolomide on the Primary Tumor in Pancreatic Neuroendocrine Tumors. North American Neuroendocrine Tumor Society. Poster presentation, NANETS Multidisciplinary Symposium,.
      4. Ikoma N, Hirata Y, Newhook T, Maxwell J, Kim M, Tran Cao H, Tzeng CD, Chun YS, Vauthey JN, Lee J, Katz M Quality of Superior Mesenteric and Hepatic Artery Dissection in Robotic Pancreatoduodenectomy for Pancreatic Cancer. International Hepato-Pancreato-Biliary Association. Video Presentation, IHPBA World Congress,.
      5. Concors SJ, Arvide EM, Prakash LR, Soones TN, Ngo-Huang AT, Nguyen VQ, Newhook TE, Ikoma N, Maxwell JE, Tran Cao HS, Chun YS, Kim M, Lee JE, Vauthey JN, Katz MHG, Tzeng CD Mitigating Serious Morbidity for Older Patients Undergoing Major Pancreatic and Hepatobiliary Surgery. Society for Surgery of the Alimentary Tract. Poster presentation, Digestive Disease Week,.
      6. Cass S, Tran Cao H, Prakash LR, Chiang Y, Maxwell J, Kim MP, Tzeng CD, Lee JE, Katz MHG Ikoma N Recurrence Patterns and Survival Outcomes after Multidisciplinary Treatment of Pancreatic Cancer. American College of Surgeons. Poster presentation, Clinical Congress,.
      7. Concors SJ, Tzeng CW, Ikoma N, Kim M, Tran Cao H, Lee JE, Katz MHG, Maxwell JE Increased Incidence, Prevalence, and Surgical Management of Enteropancreatic Neuroendocrine Tumors Parallels Improvements in Survival – A Contemporary Analysis. North American Neuroendocrine Tumor Society. Poster presentation, NANETS Multidisciplinary Symposium,.
      8. Ayabe R, Prakash L, Bruno M, Arvide E, Dewhurst W, Kim M, Maxwell J, Ikoma N, Lee J, Katz M, Tzeng C Differential Gains in Surgical Outcomes for High-Risk vs. Low-Risk Pancreatoduodenectomy with Three Successive Refinements of Risk-Stratified Care Pathways. WSA Annual Meeting. Poster presentation, Western Surgical Association,.
      9. Cass S, Maxwell JE, Bruno M, Arvide M, Dewhurst W, Prakash L, Newhook T, Kim MP, Tran Cao H, Tzeng CD, Lee JE, Katz MHG, Ikoma N Assessment of Short-Term Outcomes after Robotic Pancreatectomy. Western Surgical Association. Poster presentation, WSA Annual Meeting,.
      10. Seo YD, Witt RG, Cass S, Lazcano R, Hudgens C, Wani K, Hernandez SD, Estrella JS, Halperin DM, Lazar AJ, Wargo JA, Maxwell JE Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors. Society of Immunotherapy of Cancer. Poster presentation, SITC Annual Meeting,.
      11. Lyu H, Maxwell JE, Lu P, Hirata Y, Prakash L, Ajith J, Schmeisser J, Ninan E, Arvide M, Bruno M, Dewhurst, Snyder R, Kim M, Tran Cao H, Tzeng C, Lee J, Katz M, Ikoma N Analysis of Hospital Costs for Robotic and Open Pancreatectomy at a Cancer Center. Society of Surgical Oncology. Poster Presentation, SSO Annual Meeting,.
      12. Boyev A, Azimuddin A, Maxwell JE, Bruno M, Dewhurst, Arvide E, Prakash L, Newhook T, Kim M, Ikoma N, Snyder R, Lee J, Katz M, Tzeng CD Classification of Post-Pancreatectomy Readmissions with Opportunities for Targeted Mitigation Strategies. Pancreas Club. Poster Presentation, Pancreas Club Annual Meeting,.
      13. Boyev A, Azimuddin A, Newhook T, Maxwell JE, Prakash L, Bruno M, Dewhurst W, Arvide E, Chiang Y, Kim M, Ikoma N, Snyder R, Lee J, Katz M, Tzeng CW Validation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria. Pancreas Club. Poster Presentation, Pancreas Club Annual Meeting,.

      Abstracts

      1. Fields BC, Hirata Y, Maxwell JE, Prakash LR, Ajith J, Schmeisser JA, Snyder RA, Kim MP, Katz MHG, Ikoma N, Tzeng CD. Differential Burden of Perioperative Costs and Postoperative Pancreatic Fistula Severity. The Americas Hepato-Pancreato-Biliary Association. Oral Presentation,. AHPBA Annual Meeting,.
      2. Fields BC, Vreeland TJ, Snyder RA, Maxwell JE, Newhook TE, Prakash LR, Kim MP, Ikoma N, Lee JE, Katz MHG, Tzeng CD. CA 19-9 Normalization Following Neoadjuvant Therapy and Yield of Laparoscopy for Pancreatic Ductal Adenocarcinoma. Society of Surgical Oncology. Oral Presentation,. SSO Annual Meeting,.
      3. Ayabe RI, Seo YD, Fields BD, Melendez B, Lazcano R, Wani K, Johnson S, Witt RG, Cass S, Chelvanambi M, Hudgens C, Hernandez SD, Ajami NJ, Wargo JA, Lazar AJ, Halperin DM, Estrella JS, Maxwell JE. Cancer Testis Antigen Expression Correlates with Stromal Natural Killer Cell Activation and Longer Overall Survival in Small Bowel Neuroendocrine Tumor. American Association for Cancer Research. Oral Presentation,. AACR Annual Meeting,.
      4. Fields BC, Azimuddin AM, Boyev A, Prakash LR, Maxwell JE, Ikoma N, Snyder RA, Kim MP, Lee JE, Katz MHG, Tzeng CD. Post-Pancreatectomy Readmission Classification System Provides Framework for Cost Reduction Efforts. Society for Surgery of the Alimentary Tract. Oral Presentation,. Digestive Disease Week,.
      5. Fields BC, Haddad A, Prakash LR, Maxwell JE, Kim MP, Ikoma N, Ikoma N, Lee JE, Katz MHG, Tzeng CD. Short- and Long-term Patency After Mesoportal Venous Reconstruction During Pancreatectomy. Society for Surgery of the Alimentary Tract. Oral Presentation,. Digestive Disease Week,.
      6. Fields BC, Ayabe RI, Seo YD, Melendez B, Lazcano R, Diggs LR, Wani K, Johnson S, Chelvanambi M, Hudgens C, Hernandez SD, Ajami NJ, Wargo JA, Lazar AJ, Halperin DM, Estrella JS, Maxwell JE. Elevated Cancer Testis Antigen Expression Corresponds to Immune Activation and Improved Survival in Small Bowel Neuroendocrine Tumors. NANETS Multidisciplinary Medical Symposium.
      7. Grewal US, Rhead B, Layng KV, Navo K, Fragkogianni M, Nepomucino VM, Gao M, Xu T, O'Rorke M, Burkard ME, Concors SJ, Maxwell J, Dillon JS, Quelle D, Ear PH, Dasari A, Bellizzi A, Howe JR, Halperin DM, Chandrasekharan C. Molecular and Immune Landscape of Early-onset versus Average-onset Well-differentiated Enteropancreatic Neuroendocrine Tumors. ASCO Gastrointestinal Cancers Symposium.
      8. Ito K, Kawaguchi Y, Panettieri E, Seki Y, Campisi A, Newhook TE, Chin YS, Tran Cao HS, Tzeng CD, Dasari A, Yao JC, Chandrasekharan C, Katz MHG, Hasegawa K, Giuliante F, Vauthey JN, Maxwell JE. Contour-Based Prognostic Modeling of Neuroendocrine Liver Metastases by Primary Site. Colorectal Liver Metastasis Consensus Conference.
      9. Wang Y, Adams A, Prakash LR, Ikoma N, Snyder R, Kim M, Tzeng C, Katz M, Lee J, Chasen B, Maxwell J. Diagnostic Accuracy of Preoperative DOTATATE PET for Nodal Staging in Pancreatic Neuroendocrine Tumors. AHPBA Annual Meeting.
      10. Woeste M, Landry J, Maxwell JE. Hepatic Abscess Risk After Liver-Directed Therapy in Patients with Pancreatic Neuroendocrine Tumors and Bilioenteric Anastomosis. Pancreas Club.
      11. Wang Y, Adams A, Prakash LR, Ikoma N, Snyder RA, Kim MP, Tzeng CD, Katz MHG, Lee JE, Chasen B, Maxwell JE. Diagnostic Accuracy of Preoperative DOTATATE PET for Nodal Staging in Pancreatic Neuroendocrine Tumors. Pancreas Club.
      12. Ito K, Kawaguchi Y, Madi M, Newhook TE, Chun YS, Tran Cao HS, Tzeng CD, Vauthey J, Maxwell JE. Time-Dependent Recurrence Risk and Prognostic Factors After Hepatic Resection for Neuroendocrine Liver Metastases. Digestive Disease Week.
      13. Hierl AN, Portuondo JI, Folkert I, Arvide E, Cristo J, Dewhurst WL, Bruno ML, Prakash L, Gamboa AC, Snyder RA, Ikoma N, Kim MP, G Katz MH, Tzeng CD, Maxwell JE. Impact of an Early Inpatient Complication Screening Algorithm after Pancreatectomy on Resource Utilization, Surgical Outcomes, and Readmissions. Digestive Disease Week.
      14. Neilson T, Gist G, Lewis KA, Prakash L, Broderick J, Yao JC, Dasari A, Chandrasekharan C, Mansfield P, Fournier K, Helmink B, Song Y, Maxwell JE. Occult Peritoneal Metastases in Small Bowel Neuroendocrine Tumors: Predictors and the Role of Surgical Exploration. Digestive Disease Week.
      15. Newton AD, Newhook TE, Prakash LR, Bruno ML, Dewhurst WL, Arvide EM, Ikoma N, Kim M, Maxwell JE, Lee JE, Katz MHG, Tzeng CD. Validation of Practice-Specific Drain Fluid Amylase Cutoffs Following Pancreaticoduodenectomy in Risk-Stratified Pancreatectomy Care Pathways. Americas Hepato-Pancreato-Biliary Association. Poster presentation, AHPBA Annual Meeting,.
      16. Swords D, Prakash L, Newhook T, Tran Cao H, Ikoma N, Maxwell J, Kim M, Lee J, Katz M, Tzeng C. Neighborhood-Level Socioeconomic Status and Outcomes in Patients with Localized Pancreatic Adenocarcinoma Treated with First-Line FOLFIRINOX. Americas Hepato-Pancreato-Biliary Association. Poster presentation, AHPBA Annual Meeting,.
      17. DiPeri, TP, Newhook, TE, Prakash, LR, Ikoma, N, Maxwell, JE, Kim, MP, Lee, JE, Katz, MHG, Tzeng, CD. Prognostic Significance of Preoperative and Postoperative CA 19-9 Normalization in Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy or Surgery First. American Hepato-Pancreato-Biliary Association. Poster presentation, AHPBA Annual Meeting,.
      18. Witt RG, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Impact of First-Day Intravenous Patient Controlled Analgesia Use on Total Inpatient Opioid Use after Pancreatectomy. Society for Asian Academic Surgeons. Poster presentation, SAAS Annual Meeting,.
      19. Ferreria Dalla Pria HR, Sharbidre K,, Javadi S, Bhosale HR, Maxwell JE, Lall CG, Morani A. Imaging Update for Hereditary Abdominopelvic Neuroendocrine Tumors. Oral presentation,. Radiological Society of North America, RSNA Annual Meeting,.
      20. Witt RG, Prakash LR, Arvide EM, Newhook TE, Bruno ML, Dewhurst WL, Maxwell JE, Lee JE, Kim MP, Katz MHG, Tzeng CD, Ikoma N. Comparative Analysis of Opioid Use Between Robotic and Open Pancreaticoduodenectomy. Society of Surgical Oncology. Poster presentation, SSO Annual Meeting,.
      21. Kim BJ, Prakash LR, Ikoma N, Kim MP, Tzeng CD, Vauthey JN, Lee JE, Katz MHG, Maxwell JE. Surgical Resection of Sporadic Pancreatic Neuroendocrine Tumors: A Two-Decade Experience at a Large Volume Cancer Center. International Hepato-Pancreato-Biliary Association. Poster presentation, IHPBA World Congress,.
      22. DiPeri TP, Newhook TE, Prakash LR, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Prognostic Significance of Preoperative and Postoperative CA 19-9 Normalization in Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy or Surgery First. International Hepato-Pancreato-Biliary Association. Poster presentation, IHPBA World Congress,.
      23. Zhao M, Prakash LR, Hill V, Maxwell JE, Newhook T, Ikoma N, Tzeng CD, Lee JE, Katz MHG, Kim MP. Development of an Accumulation Index to Identify Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasms with Underlying Malignancy. Society for Surgery of the Alimentary Tract. Poster presentation, Digestive Disease Week,.
      24. Kim BJ, Prakash LR, Ikoma N, Kim MP, Tzeng CD, Vauthey JN, Lee JE, Katz MHG, Maxwell JE. Surgical Resection of Sporadic Pancreatic Neuroendocrine Tumors: A Two-Decade Experience at a Large Volume Cancer Center. Pancreas Club. Poster presentation, Pancreas Club Annual Meeting,.
      25. Zhao M, Prakash LR, Hill V, Chiang Y, Lee J, Ross WA, Coronel E, Ge PS, Weston BR, Maxwell JE, Newhook TE, Tzeng CD, Ikoma N, Lee JE, Katz MHG, Bhutani MS, Kim MP. Cyst Fluid Glucose Levels are Superior to Cyst Fluid CEA Levels for Identification of Mucinous Pancreatic Cysts. Society for Surgery of the Alimentary Tract. Poster presentation, Digestive Disease Week,.
      26. Zhao M, Hill VF, Prakash LR, Maxwell JE, Tzeng CD, Ikoma N, Lee JE, Katz MHG, Kim MP. Features of Main Duct (MP) and Mixed Intraductal Papillary Mucinous Neoplasms (IPMNs) Associated with Malignant Progression. Society of Asian Academic Surgeons. Oral presentation,. SAAS Annual Meeting,.
      27. Lilley EJ, Maxwell J, Newhook TE, Ikoma N, Tzeng CD, Badgwell B, Lee JE, Vauthey JN, Katz MHG, Tran Cao HS. Hospital Volume and Regional Variation are Associated with Palliative Surgery for Patients with Metastatic Gastrointestinal Malignancies. Society of Asian Academic Surgeons. Oral presentation,. SAAS Annual Meeting,.
      28. Ikoma N, Hirata Y, Newhook T, Maxwell J, Kim M, Tran Cao H, Tzeng DC, Chun YS, Vauthey JN, Lee J, Katz M. Strategic Approach to Building a Robotic Foregut Surgical Oncology Program at a Tertiary Care Center. Society of Asian Academic Surgeons. Oral presentation,. SAAS Annual Meeting,.
      29. Zhao M, Prakash LR, Hill VF, Maxwell JE, Newhook TE, Ikoma N, Tzeng CD, Lee JE, Katz MHG, Kim MP. Characterization and Progression of Innumerable Side-Branch IPMNs (ISB-IPMNs). Academic Surgical Congress. Poster presentation, ASC Annual Meeting,.
      30. Boyev A, Prakash LR, Jain A, Newhook TE, Chiang Y, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Maxwell JE, Ikoma N, Lee JE, Katz MHG, Tzeng CD. Sustained Reductions in Opioid Volumes Through Iterative Refinement of Pancreatectomy Pathways. American College of Surgeons. Oral presentation,. Clinical Congress,.
      31. Boyev A, Prakash LR, Chiang Y, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Tzeng CD, G Katz MH, Maxwell JE. Elevated CA 19-9 is Associated with Worse Survival in Resected Ampullary Carcinoma. Oral Presentation,. Pancreas Club, Pancreas Club Annual Meeting,.
      32. Seo YD, Witt RG, Cass S, Lazcano R, Hudgens C, Wani K, Hernandez SD, Estrella JS, Halperin DM, Lazar AJ, Wargo JA, Maxwell JE. Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors. Society of Surgical Oncology. Oral presentation,. SSO Annual Meeting,.
      33. Hirata Y, Maxwell JE, Kim MP, Tzeng CD, G Katz MH, Ikoma N. Transmesocolic Approach for Robotic Duodenal Operations. Society of Surgery of the Alimentary Tract. Poster Presentation, Digestive Disease Week,.
      34. Boyev A, Newhook T, Prakash L, Bruno M, Arvide E, Dewhurst W, Chiang Y, Kim M, Ikoma N, Lee JE, Snyder R, Katz M, Tzeng CD, Maxwell JE. Association of Postoperative Opioid Use with Pancreatic Fistula Rates After Distal Pancreatectomy. Pancreas Club. Oral plenary presentation,. Pancreas Club Annual Meeting,.
      35. Boyev A, Azimuddin A, Newhook T, Maxwell JE, Parakash L, Bruno M, Dewhurst A, Arvide E, Chiang Y, Kim M, Ikoma N, Snyder R, Lee J, Katz M, Tzeng CW. Validation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria. Society of Surgery of the Alimentary Tract. Oral plenary presentation,. Society of Surgery of the Alimentary Tract Residents & Fellows Research Conference, Digestive Disease Week,.
      36. Boyev A, Azimuddin A, Maxwell JE, Bruno M, Dewhurst WL, Arvide E, Prakash L, Newhook T, Kim M, Ikoma N, Snyder R, Lee J, Katz M, Tzeng CD. Classification of Post-Pancreatectomy Readmissions with Opportunities for Targeted Mitigation Strategies. Society of Surgery of the Alimentary Tract. Oral presentation,. Digestive Disease Week,.
      37. Boyev A, Azimuddin A, Newhook T, Mawell JE, Prakash L, Bruno M, Dewhurst W, Arvide E, Chiang Y, Kim M, Ikoma N, Snyder R, Lee J, Katz M, Tzeng CW. Validation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria. Society of Surgery of the Alimentary Tract. Oral presentation,. Digestive Disease Week,.
      38. Boyev A, Newhook T, Prakash L, Bruno M, Arvide E, Dewhurst W, Chiang Y, Kim M, Ikoma N, Lee JE, Snyder R, Katz M, Tzeng CD, Maxwell JE. Association of Postoperative Opioid Use with Pancreatic Fistula Rates After Distal Pancreatectomy. Americas Hepato-Pancreato-Biliary Association. Oral presentation,. AHPBA Annual Meeting,.
      39. David SY, Brenda M, Rossana LS, Fields Brittany C, Wani Khalida M, Sarah J, Russell W, Manoj C, Courtney H, Hernandez Sharia D, Ajami Nadim J, Ann WJ, Lazar Alexander J, Halperin Daniel M, Jeannelyn E, Maxwell JE. Cancer Testis Antigen Expression Correlates with High Type-I Interferon Signal and Improved Overall Survival in Small Bowel Neuroendocrine Tumors. NET Research Foundation. Poster Presentation, NETRF Research Symposium,.

      Book Chapters

      1. Maxwell JE, Howe, JR. Neuroendocrine Tumors of the Small Intestine. In: Lange Endocrine Surgery: Clinical Diagnosis and Management. 1. McGraw-Hill, 2025.
      2. Paez-Arrango N, Maxwell JE. Pancreatic Neuroendocrine Tumors and Multiple Endocrine Neoplasia (MEN). In: MD Anderson Surgical Oncology Manual. 7. Wolters Kluwer, 2023.
      3. Maxwell JE, Dillon JS, Halperin DM. Neuroendocrine Tumor Syndromes and Carcinoid Syndrome. In: DeGroot’s Endocrinology. 8th. Saunders Publishing, 2023.
      4. Maxwell JE, Sugg SL. Axillary Lymphadenectomy for Melanoma. In: Chassin’s Operative Strategy in General Surgery: An Expositive Atlas. 5. Springer, 2022.
      5. Maxwell JE, Halperin DM, Yao JC. Neuroendocrine Tumors. In: The MD Anderson Manual of Medical Oncology. 4. McGraw-Hill, 2022.
      6. Maxwell JE, Howe JR. Total Thyroidectomy. In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      7. Maxwell JE, Howe JR. Thyroid Lobectomy. In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      8. Maxwell JE, Hoshi H. Distal Gastrectomy with D2 Nodal Dissection, Roux en Y Reconstruction. In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      9. Maxwell JE, Howe JR. Open Liver Ablation. In: Operative Dictations in General and Vascular Surgery, 3rd ed. 3. Springer, 2017.
      10. Maxwell JE, Howe JR. Open Pancreatic Lesion Enucleation. In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      11. Maxwell JE, Howe JR. Gastrointestinal Neuroendocrine Tumors. In: Textbook of General Surgical Oncology. 1. McGraw-Hill, 2017.
      12. Maxwell JE, Hoshi H. Total Gastrectomy with D2 Nodal Dissection, Roux en Y Reconstruction, Feeding Tube Jejunostomy. In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      13. Maxwell JE, Howe JR. Parathyroidectomy for Secondary or Tertiary Hyperparathyroidism. In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      14. Maxwell JE, Howe JR. Laparoscopic Liver Ablation. In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      15. Maxwell JE, Howe JR. Laparoscopic Pancreatic Lesion Enucleation. In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      16. Maxwell JE, Hoshi H. Left Hepatic Lobectomy (intrahepatic Glissonian approach). In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      17. Maxwell JE, Hoshi H. Right Hepatic Lobectomy (extrahepatic ligation). In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      18. Maxwell JE, Hoshi H. Right Hepatic Lobectomy (intrahepatic Glissonian approach). In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      19. Maxwell JE, Howe JR. Radioisotope-guided Parathyroidectomy. In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      20. Maxwell JE, Howe JR. Parathyroidectomy for Adenoma. In: Operative Dictations in General and Vascular Surgery. 3. Springer, 2017.
      21. Maxwell JE, Howe JR. Pancreatic Neuroendocrine Tumors: Classification, Clinical Picture, Diagnosis and Therapy. In: Blumgart’s Surgery of the Liver, Biliary Tract, and Pancreas. 6. ElsevierHealth, 2016.
      22. Maxwell JE, Yao JC, Chandresekharan C. Neuroendocrine Tumors. In: The MD Anderson Manual of Medical Oncology. 5. McGraw-HIll.
      23. Maxwell JE, Dillon, JS, Halperin, DM. Neuroendocrine Tumor Syndromes and Carcinoid Syndrome. In: DeGroot's Endocrinology. 9th. Saunders Publishing.
      24. Gingrich AA, Maxwell JE. Routine Genetic Testing in Patients with Pancreatic Neuroendocrine Tumors. In: Difficult Decisions in Surgical Oncology: An Evidence-Based Approach. Springer Nature.
      25. Fields BC, Maxwell JE. Nonfunctional Pancreas Neuroendocrine Tumors. In: Surgery of the Liver, Gallbladder and Pancreas. Springer Nature.

      Web Publications

      1. Maxwell JE. "Hepatopancreatobiliary Surgery Fellowship." Author of website content. 2022. Available at https://www.mdanderson.org/education-training/clinical-research-training/graduate-medical-education/residencies-fellowships/hepatopancreatobiliary-surgery-fellowship.html.
      2. Sherman SK, Maxwell JE, Carr JC, Wang D, Bellizzi AM, O'Dorisio MS, O'Dorisio TM, Howe JR. "University of Iowa Neuroendocrine Metastasis Calculator." 2014. Available at: http://myweb.uiowa.edu/sksherman/netcalc.html.
      3. Maxwell JE. "Surgical Oncology, Section of Hepatopancreatobiliary Surgery." Author of website content. 2023 Available at https://www.mdanderson.org/education-training/clinical-research-training/graduate-medical-education/residencies-fellowships/hepatopancreatobiliary-surgery-fellowship.html.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top